New guideline revision paper “takes into account lessons learnt” from fatal Bial trial
comes as multiple sclerosis drug Tecfidera achieves improved sales growth
European nod for first pan-genotypic treatment
follows recent FDA licensing
Four-year pharma agreement will save an
Bladder cancer therapy drug seems set for rapid growth
Drug to be available on the NHS for DMD patients aged five and over
two-drug therapy Qtern presents first-to-market advantage in Europe
pipeline candidate agreement worth up to $2.5bn should Celgene claim the rights
The Partners Health revamps branding as
part of marketing drive
How good stories can drive value for brands, products and companies
Digital technologies are bringing healthcare professionals (HCPs) and their patients ever closer, and the potential benefits of this type of engagement seem to be many.
Earlier this year, the European Commission published a broad-ranging plan to digitise EU industries to help usher in what has become known as the fourth industrial revolution.
verdict by November for BMS’ ‘breakthrough’ SCCHN therapy
However, warns of lesser profits this year as firm looks to boost promotion of
Med comms agency joins forces with clinical
and regulatory consultancy
Failed to improve progression-free survival when compared with its MabThera/Rituxan therapy
Follows group's recent acquisition of
Italian firm Italchimici
FDA rejects accelerated marketing application for Raxone to await phase II trial results
And benchmarking report finds UAE best
placed to meet healthcare challenges
He becomes vice president of oncology
He becomes chairman of the board
Nicole Burns and Paul Andrews join the
Steven Holtzman succeeds interim CEO Kevin
Trevor Pill, Alex Gandhi and Ryan Gibson
join the agency
Subscribe to our email news alerts
A new reality for healthcare
- When mobile phones came onto the mass market it would have been difficult to see how they were to develop into the ubiquitous multimedia devices they are now. Their power,...
- Are you getting these benefits from your digital technology?
- Your organisation switched from ‘paper to glass’, buying the latest mobile devices and hiring digital agencies to fill them with eye-catching content. But what happened?...
Alzheimer's: the numbers we cannot forget
- In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as looking at the some of the...